Suranganie Dharmawardhane to Receptor, erbB-2
This is a "connection" page, showing publications Suranganie Dharmawardhane has written about Receptor, erbB-2.
Connection Strength
0.178
-
Borrero-Garc?a LD, Del Mar Maldonado M, Medina-Vel?zquez J, Troche-Torres AL, Velazquez L, Grafals-Ruiz N, Dharmawardhane S. Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer. BMC Cancer. 2021 Jun 01; 21(1):652.
Score: 0.178